{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:27Z","timestamp":1786991127602,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2022.109632","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T11:27:16Z","timestamp":1672486036000},"page":"109632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["CircVAPA contributes to hyper-proliferation and inflammation of keratinocytes through miR-125b-5p\/sirt6 axis in psoriasis"],"prefix":"10.1016","volume":"115","author":[{"given":"Hongdong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109632_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2020.101598","article-title":"LOC285194 inhibits proliferation of human keratinocytes through regulating miR-616\/GATA3 pathway","volume":"53","author":"Lin","year":"2020","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.intimp.2022.109632_b0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1590\/abd1806-4841.20175603","article-title":"Moderate to severe psoriasis treatment challenges through the era of biological drugs","volume":"92","author":"Vide","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.intimp.2022.109632_b0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40257-017-0337-2","article-title":"Malignancy risk and recurrence with psoriasis and its treatments: a concise update","volume":"19","author":"Geller","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2022.109632_b0020","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2022.109632_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2022.109632_b0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2022.109632_b0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrn.2017.42","article-title":"The brain, sirtuins, and ageing","volume":"18","author":"Satoh","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2022.109632_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-016-0224-3","article-title":"Sirtuin functions and modulation: from chemistry to the clinic","volume":"8","author":"Carafa","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.intimp.2022.109632_b0045","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1681\/ASN.2017111218","article-title":"Sirtuins in renal health and disease","volume":"29","author":"Morigi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109632_b0050","first-page":"H1375","article-title":"The role of sirtuins in cardiac disease","volume":"309","author":"Matsushima","year":"2015","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.intimp.2022.109632_b0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/ars.2017.7178","article-title":"SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection","volume":"28","author":"D'Onofrio","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2022.109632_b0060","first-page":"19","article-title":"Sirt1 protects against oxidative stress-induced apoptosis in fibroblasts from psoriatic patients: a new insight into the pathogenetic mechanisms of psoriasis","author":"Becatti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109632_b0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/13510002.2019.1658377","article-title":"Salidroside inhibits MAPK, NF-\u03baB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation","volume":"24","author":"Xu","year":"2019","journal-title":"Redox Rep.: Commun. Free Radical Res."},{"key":"10.1016\/j.intimp.2022.109632_b0070","first-page":"157","article-title":"Abnormal expression of SIRTs in psoriasis: decreased expression of SIRT 1\u20135 and increased expression of SIRT 6 and 7","volume":"44","author":"Fan","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2022.109632_b0075","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0394632016662475","article-title":"Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-\u03b3 in psoriatic patients","volume":"29","author":"Rasheed","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109632_b0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.intimp.2022.109632_b0085","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1002\/jcb.29685","article-title":"LncRNA RP6-65G23.1 accelerates proliferation and inhibits apoptosis via p-ERK1\/2\/p-AKT signaling pathway on keratinocytes","volume":"121","author":"Duan","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2022.109632_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ncrna.2020.06.002","article-title":"The eminent roles of ncRNAs in the pathogenesis of psoriasis","volume":"5","author":"Ghafouri-Fard","year":"2020","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.intimp.2022.109632_b0095","article-title":"Characterization of circular RNA transcriptomes in psoriasis and atopic dermatitis reveals disease-specific expression profiles","author":"Moldovan","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2022.109632_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000493952","article-title":"Circular RNA expression profile and analysis of their potential function in psoriasis","volume":"50","author":"Qiao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2022.109632_b0105","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203130","article-title":"Circ_0061012 contributes to IL-22-induced proliferation, migration and invasion in keratinocytes through miR-194-5p\/GAB1 axis in psoriasis","volume":"41","author":"He","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.intimp.2022.109632_b0110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.omtn.2020.08.001","article-title":"hsa_circ_0003738 inhibits the suppressive function of tregs by targeting miR-562\/IL-17A and miR-490-5p\/IFN-\u03b3 signaling pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.intimp.2022.109632_b0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bjd.14916","article-title":"Ubiquitin-specific peptidase 2 as a potential link between microRNA-125b and psoriasis","volume":"176","author":"Wei","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2022.109632_b0120","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2011.55","article-title":"MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2","volume":"131","author":"Xu","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2022.109632_b0125","first-page":"e6798","article-title":"miRNA125b downregulation: a review of the novel paradigm of psoriasis epigenetic regulation","volume":"12","author":"Suwanwongse","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2022.109632_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","article-title":"Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice","volume":"53","author":"Gao","year":"2020","journal-title":"Biol. Res."},{"key":"10.1016\/j.intimp.2022.109632_b0135","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.4049\/jimmunol.0902464","article-title":"Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis","volume":"184","author":"Guilloteau","year":"2010","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"key":"10.1016\/j.intimp.2022.109632_b0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif)"},{"key":"10.1016\/j.intimp.2022.109632_b0145","first-page":"894","article-title":"Comorbidities in patients with psoriasis","volume":"28","author":"Sultana","year":"2019","journal-title":"Mymensingh Med. J.: MMJ"},{"key":"10.1016\/j.intimp.2022.109632_b0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3892\/etm.2021.9878","article-title":"Role of the long non-coding RNA HOTAIR\/miR-126 axis in an in vitro psoriasis model","volume":"21","author":"Zha","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2022.109632_b0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease: From the bench to the clinic","volume":"187","author":"Han","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2022.109632_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101746","article-title":"Role of circular RNAs in brain development and CNS diseases","volume":"186","author":"Mehta","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2022.109632_b0165","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1002\/jcp.27384","article-title":"Circular RNA in cardiovascular disease","volume":"234","author":"Altesha","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2022.109632_b0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-019-1125-9","article-title":"Roles of circRNAs in the tumour microenvironment","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2022.109632_b0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2019.00639","article-title":"Roles of CircRNAs in autoimmune diseases","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109632_b0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/humc.2019.079","article-title":"Circular RNA circVAPA promotes cell proliferation in hepatocellular carcinoma","volume":"30","author":"Liu","year":"2019","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.intimp.2022.109632_b0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12935-020-01178-y","article-title":"Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a\/CREB5 axis","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2022.109632_b0190","first-page":"1245","article-title":"The complexity of the translation ability of circRNAs","volume":"1859","author":"Granados-Riveron","year":"2016","journal-title":"BBA"},{"key":"10.1016\/j.intimp.2022.109632_b0195","doi-asserted-by":"crossref","first-page":"18392","DOI":"10.18632\/aging.203287","article-title":"Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1\/STAT3 signaling","volume":"13","author":"Lv","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.intimp.2022.109632_b0200","doi-asserted-by":"crossref","unstructured":"W.H. Chuo, Y.T. Tung, C.L. Wu, Alantolactone suppresses proliferation and the inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced skin lesions in a Psoriasis-like mouse model. 11 (2021).","DOI":"10.3390\/life11070616"},{"key":"10.1016\/j.intimp.2022.109632_b0205","doi-asserted-by":"crossref","first-page":"e3325","DOI":"10.1002\/jgm.3325","article-title":"CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p\/WNT5A axis","volume":"23","author":"Zhao","year":"2021","journal-title":"J. Gene Med."},{"key":"10.1016\/j.intimp.2022.109632_b0210","doi-asserted-by":"crossref","unstructured":"H. Chen, Y. Zhang, K. Wu, X. Qiu, circVAPA promotes the proliferation, migration and invasion of oral cancer cells through the miR-132\/HOXA7 axis, J. Int. Med. Res. 49 (2021) 3000605211013207.","DOI":"10.1177\/03000605211013207"},{"key":"10.1016\/j.intimp.2022.109632_b0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3748\/wjg.v27.i6.487","article-title":"Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p\/STAT3 axis","volume":"27","author":"Deng","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2022.109632_b0220","first-page":"993","article-title":"MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6","volume":"8","author":"Song","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.intimp.2022.109632_b0225","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2022.109632_b0230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjd.17256","article-title":"Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis","volume":"180","author":"Yan","year":"2019","journal-title":"Br. J. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922011171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922011171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:05:07Z","timestamp":1736413507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922011171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"alternative-id":["S1567576922011171"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109632","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CircVAPA contributes to hyper-proliferation and inflammation of keratinocytes through miR-125b-5p\/sirt6 axis in psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109632"}}